Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Studies have linked early deaths and asthma exacerbations to chronic exposure to particulate matter in wildfire smoke.

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...